- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs for hyperuricemia
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 24, Issue 8, Pages 1013-1030
Publisher
Informa Healthcare
Online
2015-06-15
DOI
10.1517/13543784.2015.1051617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New medications in development for the treatment of hyperuricemia of gout
- (2015) Cesar Diaz-Torné et al. CURRENT OPINION IN RHEUMATOLOGY
- Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
- (2015) Katherine C. Allen et al. DRUG SAFETY
- Impact of hyperuricaemia on the chronic kidney disease-associated risk factors in a community-based population
- (2015) Yoshiko Tsumuraya et al. NEPHROLOGY
- Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
- (2015) Matthew J Roughley et al. ARTHRITIS RESEARCH & THERAPY
- Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A U.S. Payer Perspective
- (2015) Pranav K. Gandhi et al. Journal of Managed Care & Specialty Pharmacy
- Uric Acid Levels, Kidney Function, and Cardiovascular Mortality in US Adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002
- (2014) Michelle C. Odden et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- FRI0389 RDEA3170, a novel, high affinity URAT1 inhibitor binds to a central domain within URAT1
- (2014) J.N. Miner et al. ANNALS OF THE RHEUMATIC DISEASES
- SAT0356 The Therapeutic Efficacy of the Novel Uricosuric Agent UR-1102 for Hyperuricemia and Gout
- (2014) S. O. Ahn et al. ANNALS OF THE RHEUMATIC DISEASES
- FRI0401 BCX4208, a novel enzyme inhibitor for chronic management of GOUT, shows a low risk of potential drug-drug interactions
- (2014) S. Bantia et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of allopurinol on risk of myocardial infarction
- (2014) L Grimaldi-Bensouda et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanism of Action of Colchicine in the Treatment of Gout
- (2014) Nicola Dalbeth et al. CLINICAL THERAPEUTICS
- Febuxostat: drug review and update
- (2014) Harmanjot K Grewal et al. Expert Opinion on Drug Metabolism & Toxicology
- Comorbidities in Patients with Crystal Diseases and Hyperuricemia
- (2014) Sebastian E. Sattui et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
- (2014) Roy Fleischmann et al. RHEUMATOLOGY
- Up-titration of allopurinol in patients with gout
- (2014) Claudine G. Jennings et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- New Therapies for Gout
- (2013) Daria B. Crittenden et al. Annual Review of Medicine
- Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies
- (2013) Eyal Grunebaum et al. Current Opinion in Allergy and Clinical Immunology
- New developments in gout
- (2013) Leslie Harrold CURRENT OPINION IN RHEUMATOLOGY
- Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase
- (2012) Mohamad Bassam Sonbol et al. AMERICAN JOURNAL OF HEMATOLOGY
- Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
- (2012) Yanyan Zhu et al. AMERICAN JOURNAL OF MEDICINE
- Clinical Risk Factors for Adverse Events in Allopurinol Users
- (2012) Hee Jung Ryu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Safety of Urate-Lowering Therapies
- (2012) Robert T. Keenan RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
- (2011) Yanyan Zhu et al. ARTHRITIS AND RHEUMATISM
- Epidemiology of gout: An update
- (2011) E.U.R. Smith et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Difficult-to-Treat Gouty Arthritis
- (2011) Naomi Schlesinger DRUGS
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
- (2011) S. CHOHAN JOURNAL OF RHEUMATOLOGY
- Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition
- (2011) Hisashi Yamanaka NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Gout. Epidemiology of gout
- (2011) Edward Roddy et al. ARTHRITIS RESEARCH & THERAPY
- Contemporary epidemiology of gout in the UK general population
- (2011) Lucía Cea Soriano et al. ARTHRITIS RESEARCH & THERAPY
- A prescription for lifestyle change in patients with hyperuricemia and gout
- (2010) Hyon K Choi CURRENT OPINION IN RHEUMATOLOGY
- Hyperuricemia and incident hypertension: A systematic review and meta-analysis
- (2010) Peter C. Grayson et al. ARTHRITIS CARE & RESEARCH
- Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with Gout
- (2010) Fernando Perez-Ruiz et al. ARTHRITIS CARE & RESEARCH
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Hyperuricemia and risk of stroke: A systematic review and meta-analysis
- (2009) Seo Young Kim et al. ARTHRITIS AND RHEUMATISM
- A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout
- (2009) Ming-Han H Lee et al. DRUG SAFETY
- Gout. Novel therapies for treatment of gout and hyperuricemia
- (2009) Robert Terkeltaub ARTHRITIS RESEARCH & THERAPY
- Adherence with urate-lowering therapies for the treatment of gout
- (2009) Leslie R Harrold et al. ARTHRITIS RESEARCH & THERAPY
- A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout
- (2009) Jeannie Chao et al. Current Rheumatology Reports
- Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension
- (2008) Daniel I. Feig et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans
- (2008) Naohiko Anzai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SLC2A9 Is a High-Capacity Urate Transporter in Humans
- (2008) Mark J Caulfield et al. PLOS MEDICINE
- PEG-uricase in the management of treatment-resistant gout and hyperuricemia
- (2007) Merry R. Sherman et al. ADVANCED DRUG DELIVERY REVIEWS
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
- (2007) Sima Halevy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now